Inactivation of hepatitis A and other enteroviruses during heat treatment (pasteurization)

Biologicals

Volumn 24, Issue 4, 1996, Pages 339-341

  Nissen, E ^a   Konig P ^a   Feinstone, S M ^a   Pauli, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROVIRUS; HEAT TREATMENT; HEPATITIS A VIRUS; PASTEURIZATION; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INACTIVATION;

EID: 0030437065     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1996.0048     Document Type: Article

References (5)

1. 1. Eriksson B, Westman L, Jernberg M. Virus validation of plasma-derived products produced by pharmacia, with particular reference to immunoglobulins. Blood Coagul Fibrinol 1994; 5 (Suppl. 3): S37-S44.
2. 2. Horowitz B, Prince AM, Hamman J, Watklevicz C. Viral safety of solvent/detergent-treated blood products. Blood Coagul Fibrinol 1994; 5 (Suppl. 3): S21-S28.
3. 3. Löwer J. Virological aspects of the quality control of biologicals: quantitative considerations. Dev Biol Stand 1991; 75: 221-226.
4. 4. Commission of the European Communities: Note for guidance of the CPMP: 'Validation of virus removal and inactivation procedures'. Biologicals 1991; 19: 247-251.
5. 5. Reed LJ, Muench H. A simple method for estimating fifty percent endpoints. Am J Hyg 1938; 27: 493-497.